SecBot SecBot
SECBOTREPLAY Home › Report › MLYS

MLYS · CEO Jon Congleton and CMO David Malcom Rodman sold a combined ~$302K in…

Mineralys Therapeutics, Inc. · CLUSTER filed Jul 20, 2026 at 21:00 ET

At the news

NEUTRALIMPACT 3/10

CLUSTER filed Jul 20, 2026 at 21:00 ET

CEO Jon Congleton and CMO David Malcom Rodman sold a combined ~$302K in MLYS stock over a 7-day window, with the CEO's $291K sale representing the bulk. The sales are modest relative to the $2.2B market cap (~0.014%), and the CMO's trades include a same-day derivative exercise and sale, suggesting tax-related or liquidity-driven selling rather than a bearish signal. The cluster is small in dollar terms and lacks the materiality to indicate informed selling.

  • CEO Jon Congleton sold 10,700 shares for ~$291K on 2026-07-13
  • CMO David Malcom Rodman sold 416 shares for ~$11K on 2026-07-17, following a derivative exercise
  • Total insider sales of ~$302K represent ~0.014% of MLYS's $2.2B market cap
  • CMO also exercised 416 derivative shares at $15.44 on 2026-07-17, a non-cash event

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access